NURO - NeuroMetrix, Inc.
4.38
-0.030 -0.685%
Share volume: 3,360
Last Updated: 04-07-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.01%
PREVIOUS CLOSE
CHG
CHG%
$4.41
-0.03
-0.01%
Fundamental analysis
15%
Profitability
0%
Dept financing
3%
Liquidity
63%
Performance
20%
Company vs Stock growth
vs
769.148 K
587.314 K
-181.834 K
-23.64%
3.160
3.550
0.390
12.34%
Performance
5 Days
-0.96%
1 Month
0.46%
3 Months
8.42%
6 Months
4.53%
1 Year
15.26%
2 Year
-62.24%
Key data
Stock price
$4.38
DAY RANGE
$4.32 - $4.39
52 WEEK RANGE
$2.66 - $4.73
52 WEEK CHANGE
$15.26
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
Company detail
CEO: Shai N. Gozani
Region: US
Website: neurometrix.com
Employees: 20
IPO year: 2004
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Region: US
Website: neurometrix.com
Employees: 20
IPO year: 2004
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
NeuroMetrix, Inc. engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy. Quell, a wearable device for symptomatic relief and management of chronic pain.
Recent news
